Ovoca Gold PLC (IR:OVXA) — Market Cap & Net Worth
Market Cap & Net Worth: Ovoca Gold PLC (OVXA)
Ovoca Gold PLC (IR:OVXA) has a market capitalization of $856.42K (€732.54K) as of May 20, 2026. Listed on the IR stock exchange, this Ireland-based company holds position #30491 globally and #23 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ovoca Gold PLC's stock price €0.01 by its total outstanding shares 81563800 (81.56 Million). Analyse Ovoca Gold PLC (OVXA) cash flow conversion to see how efficiently the company converts income to cash.
Ovoca Gold PLC Market Cap History: 2015 to 2025
Ovoca Gold PLC's market capitalization history from 2015 to 2025. Data shows change from $7.63 Million to $1.00 Million (-19.68% CAGR).
Index Memberships
Ovoca Gold PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ISEQ Overall
ISEQ
|
$98.65 Billion | 0.00% | #22 of 31 |
Weight: Ovoca Gold PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ovoca Gold PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ovoca Gold PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OVXA by Market Capitalization
Companies near Ovoca Gold PLC in the global market cap rankings as of May 20, 2026.
Key companies related to Ovoca Gold PLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.23 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #422 globally with a market cap of $64.93 Billion USD.
- argenx NV ADR (NASDAQ:ARGX): Ranked #570 globally with a market cap of $45.97 Billion USD.
- UCB S.A. UNSP.ADR 1/2 (F:UNC0): Ranked #587 globally with a market cap of $44.84 Billion USD ( €38.35 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.23 Billion | $434.31 |
| #422 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.93 Billion | $630.30 |
| #570 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
| #587 | UCB S.A. UNSP.ADR 1/2 | F:UNC0 | $44.84 Billion | €120.00 |
Ovoca Gold PLC Historical Marketcap From 2015 to 2025
Between 2015 and today, Ovoca Gold PLC's market cap moved from $7.63 Million to $ 1.00 Million, with a yearly change of -19.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €1.00 Million | -30.00% |
| 2024 | €1.43 Million | +50.00% |
| 2023 | €953.57K | -83.33% |
| 2022 | €5.72 Million | -60.00% |
| 2021 | €14.30 Million | +57.89% |
| 2020 | €9.06 Million | -20.17% |
| 2019 | €11.35 Million | +13.33% |
| 2018 | €10.01 Million | +28.05% |
| 2017 | €7.82 Million | -36.43% |
| 2016 | €12.30 Million | +61.25% |
| 2015 | €7.63 Million | -- |
End of Day Market Cap According to Different Sources
On May 1st, 2026 the market cap of Ovoca Gold PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $856.42K USD |
| MoneyControl | $856.42K USD |
| MarketWatch | $856.42K USD |
| marketcap.company | $856.42K USD |
| Reuters | $856.42K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ovoca Gold PLC
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It's lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporate… Read more